Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Trouble using our website?
Contact us

Dr Yannick Lemer

In this page

Member info

Dr Yannick Lemer

Representative

France

Team

Dr Elise Boulanger-Scemana

France

See more

Dr Catherine Vignal-Clermont

France

Neuro-Ophthalmology Rare Diseases (WG2)
Working Group Leader
See more

HCP Center

Created in 1905, thanks to a bequest from Baron Adolphe de Rothschild, the Rothschild Foundation Hospital is a university hospital recognised...

contact

Fondation Adolphe de Rothschild, Paris, France

25-29 Rue Manin
75019 Paris
France

Clinical trials

NCT04448613 Recruiting, Active

Precise High Resolution MRI to Increase Accuracy and Gain Confidence to Diagnose Patients With Optic Disc Edema (PAGODE)

Observational
See the trial
voir la fiche
NCT04448938 Active, Not recruiting

RESting-state Functional MRI in Patients With Optic Neuritis for ANticipation of reCovEry

Observational
See the trial
voir la fiche

NCT04793100 Active, Not recruiting

Spontaneous Retinal Artery Pulses (SPARs) as a Prognostic Determinant of Central Retinal Vein Occlusions (CRVO) in Patients With or Without Intravitreal Aflibercept Injections

Interventional
See the trial
voir la fiche
NCT03940690 Suspended

Interest of Intravitreal Injections of Anti-VEGF as Initial and Adjuvant Treatment in Coats Disease.

Interventional
See the trial
voir la fiche
NCT03662386 Recruiting, Active

Prospective Analysis of «Genotype-phenotype» Correlations Observed in a LargeCohort of Patients With Hereditary Retinal Dystrophies - GEPHIRD

Observational
See the trial
voir la fiche
NCT02796274 Completed

Historical Case Record Survey of Visual Acuity Data From Patients With Leber’s Hereditary Optic Neuropathy (LHON).

Interventional
See the trial
voir la fiche
NCT04435366 Completed

A Phase 3 Multicenter, Randomized, Double Masked, Sham- Controlled Clinical Trial to Assess the Safety and Efficacy of Intravitreal Administration of Zimura (Complement C5 Inhibitor) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Interventional
See the trial
voir la fiche
NCT05536297 Active, Not recruiting

Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy

Interventional
See the trial
voir la fiche
NCT04276558 Recruiting, Active

Efficacy, Safety and Pharmacokinetics of 3 Doses of REC 0/0559 Eye Drops for the Treatment of Stage 2 (Moderate) and 3 (Severe) Neurotrophic Keratitis in Adult Patients

Interventional
See the trial
voir la fiche
NCT01756456 Completed

Evaluation of safety and efficacy of r-hNGF in patients with stage 2 and 3 Neurotrophic Keratitis (REPARO).

Interventional
See the trial
voir la fiche
NCT04939571 Recruiting, Active

European Disease Registry on Retinopathy of Prematurity (ROP)

Observational
See the trial
voir la fiche